Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Case conference Presented by Intern:吳勝騰 Patient profile • • • • • Name:林高o珠 Age: 48 Gender: female Chart number: 04796365 Admitted to our ward on 98/4/10 2 Chief complaint • Yellowing of the sclera was noted since 4/8 3 Present illness • This 48 years old woman is a patient of chronic hepatitis B, diagnosed on 民國85年. • She suffered from icteric sclera since 4/8. She also complained of RUQ area abdominal discomfort without tenderness. • Other associated symptoms included – fever (-), chills (-), fatigue(+) , body weight loss(-) – mental disturbance or behavior change (-), general weakness (+), insomnia(+) – RUQ tenderness(-), anorexia(-), hunger pain (-), post prandial pain (-), diarrhea (-), nausea (-), vomiting (-) ,tarry stool(+/-), bloody stool(-) – arthralgia (-), myalgia(-) – Yellowing of the skin(+), itching of the skin(-) 4 Present illness • She denied recent blood transfusion, tattoos, or other Chinese herb use. • Then she went to 輔英 hospital for help on 4/9, where elevated GOT(824), GPT(1654), total bilirubin(7.19), AFP(169) and PT prolong(17.5/10.2, INR 1.78) were found. Then she was transferred to our hospital for help on 4/10. • At emergent department, vital sign was BP 155/92 mmHg, HR 129 beat/min, RR 20 times/min, BT 36.7 'C. • Under the impression of chronic hepatitis B with acute exacerbation, she was admitted for further evaluation and management. 5 Past history • DM(-), Hypertension(-) • Heart disease(-), renal disease(-) • HBV, HCV: chronic hepatitis B – HBsAg(+), Anti-HCV(-) (85.08.05) • Operation history: hysterectomy about 5-6 years ago 6 Social history • • • • Cigarette Smoking : denied Alcohol : denied Occupation history : 櫻花蝦製作 Contact history : denied blood transfusion, IV drug or Chinese herb use, tattoo • Travel history : denied • Allergy history: no known drug allergy 7 Physical examination (ER) • Consiousness: alert, E4V5M6 • Vital sign: – BP: 155 / 92 mmHg, PR: 129 bpm, RR: 20 cpm, BT: 36.7 ℃ • Head: – Conjunctiva: not pale, not injected Sclera: icteric • Neck: – supple, Lymphadenopathy (-), jugular venous distension(-) • Chest: symmetric expansion – spider angioma(-) – Heart sound: regular heart beat without murmur – Breath sound: bilateral clear, no wheezing, no crackle 8 Physical examination (ER) • Abdomen: soft and mild distended, caput medusae(-) Bowel sound: normoactive Percussion: tympanic, shifting dullness(-) tenderness (-) rebounding pain(-) Murphy sign(-) Mcberney sign(-) Liver / Spleen: impalpable • Extremities: freely movable, lower limbs slight pitting edema • Skin: no rash or ecchymosis, no jaundice, palmar erythema(-), 9 Laboratory data from ER 10 Laboratory data from ER 11 Tentative diagnosis • Chronic hepatitis B with acute exacerbation, cause to be determined – other causes of viral hepatitis: HCV,CMV, EBV, HSV, VZV could not be excluded – other causes of autoimmune hepatitis could not be excluded 12 management • Anti-viral drug: Zeffix 1# BID PC • supportive care – Colin 1# TID PC – IVF supply due to poor oral intake • survey acute hepatitis cause – Recheck anti-HCV Ab – Check ANA to rule out autoimmune hepatitis – Arrange abdominal echo • follow up liver function • monitor s/s of acute hepatic failure and hepatic encephalopathy 13 14 15 16 17 Liver function data during hospitalization ANA : Negative (4/11) 18 Liver function data during hospitalization GOT GPT 19 Liver function data during hospitalization Total bilirubin Albumin 20 Liver function data during hospitalization PT 21 management • supportive care – Hold possible toxic medication (arcoxia?) – Procam 1# TIDPC – IVF supply due to poor oral intake • survey acute hepatitis cause – Check HCV RNA – Check ANA to rule out autoimmune hepatitis – Arrange abdominal echo • follow up liver function • monitor s/s of acute hepatic failure and hepatic encephalopathy 22 Topic: Acute liver failure Definition • definitions of the time course – The development of encephalopathy within 8 weeks of the onset of symptoms in a patient with a previously healthy liver – The appearance of encephalopathy within 2 weeks of developing jaundice, even in a patient with previous underlying liver dysfunction 24 Etiology-1 • acute viral hepatitis – HAV, HBV, HCV(rare), HDV coinfection or superinfection, HEV (especially in pregnant women), EBV, CMV, HSV, and varicella zoster – Hepatitis B is probably the most common viral cause – Viral serologies • • • • Hepatitis A IgM antibody Hepatitis B surface antigen Hepatitis B core IgM antibody Hepatitis C viral RNA 25 • Acute hepatitis C – account for approximately 20 % of acute viral hepatitis in the United States – marker • Serum HCV RNA detectable by PCR :days to 8 weeks following exposure • Serum aminotransferases elevated : 6 to 12 weeks after exposure • Anti-HCV ELISA tests positive : eight weeks after exposure – The risk of chronic infection after an acute episode of hepatitis C is high, especially in asymptomatic patient. 26 Etiology-2 • shock liver (ischemic hepatitis) – prolonged period of systemic hypotension (such as patients with severe heart failure) – Striking increases in serum aminotransferases and lactic dehydrogenase – Other vascular cause • acute Budd-Chiari syndrome, hepatic sinusoidal obstruction syndrome, hepatic infarction. • Diagnostic: ultrasound, abdominal CT, Doppler 27 Etiology-3 • acute drug- or toxin-induced liver injury – Predictable/ Unpredictable(idiosyncratic) – medication/toxin • Dose-dependent: acetaminophen • NSAID, antibiotics, statins, antiepileptic drugs, and antituberculous drugs, herbal preparations • CCl4, fluorinated hydrocarbons, Amanita phalloides 28 Etiology-4 • autoimmune hepatitis – primarily in young to middle-aged women – elevated serum aminotransferases, the absence of other causes of chronic hepatitis, and serological and pathological features – screening test • serum protein electrophoresis (hyper-gammaglobulinemia ) • ANA, SMA, and liver-kidney microsomal antibodies (LKMA) • Liver biopsy – Treatment: long-term prednisone +/- azathioprine 29 Etiology-5 • Metabolic – Wilson's disease • genetic disorder of biliary copper excretion • patients <40, particularly those who have concomitant hemolytic anemia • ALP/bilirubin<2; ALP often low in fulminant disease • initial screening test: reduced serum ceruloplasmin – Kayser-Fleischer rings – 24-hour urine copper excretion>100 mcg/day – liver copper levels >250 mcg/gm of dry weight • Treatment – Chelation therapy with penicillamine + pyridoxine 30 Etiology-6 – acute fatty liver of pregnancy – HELLP syndrome – Reye's syndrome – malignant infiltration of the liver, heat stroke, sepsis 31 Prognosis • The mortality in FHF – higher for idiosyncratic drug reactions, Wilson's disease, and non-A and non-B hepatitis and – lower for cases of FHF caused by hepatitis A, hepatitis B, and acetaminophen • the height of the aminotransferase elevation generally has no prognostic value. • AST and ALT ↓↓, plasma bilirubin↑and prothrombin time↑ => indicative of a poor prognosis 32 Thank you very much ! Thank you very much ! 34 35 EGD 36 Abdominal echo 37